Suppr超能文献

独立于肾切除术,免疫抑制药物的逐渐撤用会导致移植肾失功后的晚期致敏。

Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.

机构信息

Department of Medicine, University Hospitals Case Medical Center, Cleveland, OH 44106, USA.

出版信息

Transplantation. 2012 Oct 15;94(7):738-43. doi: 10.1097/TP.0b013e3182612921.

Abstract

BACKGROUND

Patients returning to dialysis therapy after renal transplant failure have a high rate of human leukocyte antigen antibody sensitization, and sensitization has been linked to allograft nephrectomy. We hypothesized that nephrectomy for cause is a consequence of weaning immunosuppression and that weaning leads to sensitization even in the absence of nephrectomy.

METHODS

We examined outcomes in 300 consecutive patients with kidney allograft failure and survival of more than 30 days after failure. We analyzed a subset of 119 patients with a low panel reactive antibody (PRA) before transplantation and follow-up PRA testing at 6 to 24 months after failure (late PRA).

RESULTS

By late PRA testing, 56% of patients were highly sensitized (class I or II PRA ≥80%). On multivariate analysis controlling for human leukocyte antigen matching, allograft nephrectomy, and other variables, weaning of immunosuppression predicted high sensitization (odds ratio, 14.34; P=0.004). In a subset of patients, the percentage of those who were highly sensitized increased from 21% at the time of failure on immunosuppressive therapy to 68% by late PRA after weaning (P<0.001). Conversely, patients who maintained immunosuppression showed minimal sensitization after failure. Transplant nephrectomy was required in 41% of patients who weaned immunosuppression versus 0% of the 24 patients who maintained immunosuppression with calcineurin inhibitor therapy after failure (P<0.001).

CONCLUSIONS

Weaning immunosuppression was a triggering event leading to late rejection and allograft nephrectomy and was an independent predictor of alloantibody sensitization after kidney allograft failure.

摘要

背景

肾移植失败后返回透析治疗的患者存在较高的人类白细胞抗原抗体致敏率,致敏与同种异体肾切除有关。我们假设,因免疫抑制脱落后导致的肾切除是致敏的结果,即使没有肾切除,脱落后也会导致致敏。

方法

我们检查了 300 例连续发生移植肾失功且失功后存活时间超过 30 天的患者的结局。我们分析了一组 119 例移植前低群体反应性抗体(PRA)的患者,以及失功后 6 至 24 个月时的后续 PRA 检测(晚期 PRA)。

结果

根据晚期 PRA 检测,56%的患者呈高度致敏状态(I 类或 II 类 PRA≥80%)。在控制人类白细胞抗原匹配、同种异体肾切除和其他变量的多变量分析中,免疫抑制脱落后预测高度致敏(优势比,14.34;P=0.004)。在患者亚组中,在免疫抑制治疗时失功的患者中,高度致敏的比例从 21%增加到脱落后晚期 PRA 时的 68%(P<0.001)。相反,在失功后继续维持免疫抑制的患者中,致敏程度最小。与继续维持免疫抑制的 24 例患者相比,免疫抑制脱落后的患者中有 41%需要进行移植肾切除(P<0.001)。

结论

免疫抑制脱落后是导致晚期排斥反应和同种异体肾切除的触发事件,也是移植肾失功后同种异体抗体致敏的独立预测因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验